SAB-181

N/A

Report date: 2025/01/26 17:10:47

Base Information

Drug NameSAB-181
Drug Alias NameHuman immunoglobulin G (SAB Biotherapeutics)SAB-181
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies
Mechanisms of ActionImmunoglobulin G agonists
TargetsImmunoglobulin G
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSab Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSab Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A